<code id='B46671247B'></code><style id='B46671247B'></style>
    • <acronym id='B46671247B'></acronym>
      <center id='B46671247B'><center id='B46671247B'><tfoot id='B46671247B'></tfoot></center><abbr id='B46671247B'><dir id='B46671247B'><tfoot id='B46671247B'></tfoot><noframes id='B46671247B'>

    • <optgroup id='B46671247B'><strike id='B46671247B'><sup id='B46671247B'></sup></strike><code id='B46671247B'></code></optgroup>
        1. <b id='B46671247B'><label id='B46671247B'><select id='B46671247B'><dt id='B46671247B'><span id='B46671247B'></span></dt></select></label></b><u id='B46671247B'></u>
          <i id='B46671247B'><strike id='B46671247B'><tt id='B46671247B'><pre id='B46671247B'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:4697
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more
          Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline
          Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

          Bayer'sU.S.president,SebastianGuth,emphasizedataninterviewattheSTATofficesinBostonthatthepharmacompa

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          White House Covid adviser calls on docs to combat misinformation

          AshishJha,coordinatoroftheWhiteHouseCovidresponseteamBRENDANSMIALOWSKI/AFPviaGettyImagesWALTHAM,Mass